[Form 4] Health Catalyst, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Albert Benjamin, President and COO of Health Catalyst, Inc. (HCAT), was granted 467,000 restricted stock units (RSUs) on 09/24/2025 under the companys 2019 Stock Option and Incentive Plan. Each RSU represents a contingent right to one share of common stock. After the grant, the filing reports 577,870 shares beneficially owned by the reporting person. The RSUs vest 33.33% on September 10, 2026, with the remaining 66.67% vesting in eight equal quarterly installments thereafter.

Positive

• 467,000 RSUs awarded to the reporting person on 09/24/2025 under the 2019 Plan
• Clear vesting schedule: 33.33% on 09/10/2026 and remaining 66.67% in eight equal quarterly installments
• Post-transaction beneficial ownership reported as 577,870 shares

Negative

• None.

Insights

Financial Analyst

TL;DR: Executive received a sizeable RSU grant (467,000 units) with multi-stage vesting; ownership reported at 577,870 shares.

The grant is a non-cash equity award disclosed on a Form 4, indicating an issuance of 467,000 RSUs to the President and COO on 09/24/2025. The filing states each RSU converts to one share upon vesting and specifies a clear vesting schedule: 33.33% on 09/10/2026 and the remainder in eight equal quarterly installments. The reported post-transaction beneficial ownership is 577,870 shares. This is a routine executive equity grant disclosure required under Section 16.

Corporate Governance Expert

TL;DR: The Form 4 documents a compensation-related equity grant with a defined vesting timetable; disclosure is complete and standard.

The filing identifies the award as RSUs granted under the 2019 Stock Option and Incentive Plan and includes the vesting mechanics. The signature block shows the filing was executed by an attorney-in-fact on 09/26/2025. The disclosure fulfills Section 16 reporting obligations by listing the transaction date, number of RSUs, and resulting beneficial ownership. No additional governance actions or amendments are disclosed in this Form 4.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Albert Benjamin

(Last) (First) (Middle)

10897 S. RIVER FRONT PARKWAY

SUITE 300

(Street)

SOUTH JORDAN UT 84095

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Health Catalyst, Inc. [ HCAT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and COO

3. Date of Earliest Transaction (Month/Day/Year)
09/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/24/2025		A		467,000(1)	A	$0.00	577,870	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on September 10, 2026 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments

Remarks:

	/s/ Benjamin Landry, as Attorney-in-Fact	09/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Health Catalyst (HCAT) disclose in this Form 4?

The Form 4 reports a grant of 467,000 restricted stock units (RSUs) to the reporting person on 09/24/2025 and lists resulting beneficial ownership of 577,870 shares.

Who received the RSU grant reported on Form 4?

The grant was made to Albert Benjamin, who is identified in the filing as President and COO of Health Catalyst, Inc.

What is the vesting schedule for the RSUs?

The RSUs vest 33.33% on September 10, 2026 and the remaining 66.67% in eight equal quarterly installments thereafter.

Under which plan were the RSUs granted?

The RSUs were granted pursuant to the issuers 2019 Stock Option and Incentive Plan.

When was the Form 4 signed and filed?

The signature block shows the form was signed by an attorney-in-fact (Benjamin Landry) on 09/26/2025.